From: The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
Group
Agea
Women (%)b
MMSEc
MCI
74.10 ± 8.81
60.3
26.58 ± 2.16
AD
74.95 ± 7.83
71.4
19.72 ± 4.80
CONTROLS
74.94 ± 10.34
59.6
28.23 ± 1.73